Covered recipient · General Payments record
LARRY O RIEDEL
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2023
$1,579.39
- Reported across 89 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $186.22 | 11 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $42.31 | 3 |
| DEXCOM, INC. | $42.21 | 2 |
| Acerta Pharma LLC | $35.21 | 2 |
| BAXTER HEALTHCARE | $20.62 | 1 |
| Novo Nordisk AS | $17.15 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.75 | 1 |
| Amgen Inc. | $12.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $12.97 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019997097 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.89 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015768193 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.32 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011364755 | CMS |
| Baxter Healthcare | $20.62 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000165759 | CMS |
| Dexcom, Inc. | $19.07 | 04/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054942543 | CMS |
| Dexcom, Inc. | $23.14 | 05/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054942549 | CMS |
| Lilly USA, LLC | $14.53 | 01/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031903173 | CMS |
| Lilly USA, LLC | $12.92 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031764815 | CMS |
| Lilly USA, LLC | $14.86 | 06/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031903177 | CMS |
| Novo Nordisk Inc | $17.15 | 02/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002543475 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.75 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057372255 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.